Consensys Software sold all 5.7 million of its SharpLink common shares for about $48 million, exiting its position after the stock price plummeted roughly 93% from its May 2025 high of $124.12 to around $8.39 per share. Despite the sale, SharpLink Chairman Joe Lubin still holds about 5 million shares directly, and Consensys retains warrants for 3.5 million shares. SharpLink's stock surged 412% in one session after announcing an Ether treasury deal in May 2025 but then sharply declined, with the company facing significant losses and potential removal from MSCI indexes, which could impact passive investment flows.
Consensys' sale of 5.7 million SharpLink shares for about $48 million follows a dramatic 93% drop in the stock price from its May 2025 peak. For readers following the broader crypto market, here is Pluang's market snapshot as of Oct 21, 2026 03:41 WIB: out of 50 major cryptocurrencies, 45 rose and 4 fell. Notable movers include SNX (Synthetix) up 4.96% with a typical hold time of 70 days, MANA (Decentraland) up 4.74% with a hold time of 157 days, and XTZ (Tezos) up 4.65% with a hold time of 101 days.
Grupo Aeroportuario del Pacífico reported Q3 2026 earnings per share of $2.66 and revenue of $632.9 million, both below analyst expectations. Despite the miss, the company saw a 13.2% rise in revenue excluding construction services and a 19.2% increa...
Northern Trust is set to report its Q3 2026 earnings with analysts forecasting a 24.9% rise in earnings per share to $2.86 and an 11.8% increase in revenue to $2.26 billion. Growth is driven by an 11.4% increase in net interest income and a 12.1% ris...
Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...
Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...
Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...
